Healthcare provider profile · identity verified

Roger Allen Pearce, MD

Internal Medicine · LONGVIEW, TX · NPI 1295706273

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	211	94
Lisinopril	Lisinopril	192	77
Amlodipine Besylate	Amlodipine Besylate	189	75
Levothyroxine Sodium	Levothyroxine Sodium	120	56
Omeprazole	Omeprazole	108	41
Rosuvastatin Calcium	Rosuvastatin Calcium	95	40
Metformin Hcl Er	Metformin Hcl	88	27
Simvastatin	Simvastatin	86	24
Albuterol Sulfate Hfa	Albuterol Sulfate	75	20
Escitalopram Oxalate	Escitalopram Oxalate	73	28
Pantoprazole Sodium	Pantoprazole Sodium	71	34
Carvedilol	Carvedilol	69	27
Losartan Potassium	Losartan Potassium	69	33
Gabapentin	Gabapentin	61	27
Tamsulosin Hcl	Tamsulosin Hcl	60	21
Celecoxib	Celecoxib	56	20
Metoprolol Succinate	Metoprolol Succinate	56	28
Jardiance	Empagliflozin	50	16
Metformin Hcl	Metformin Hcl	50	19
Ezetimibe	Ezetimibe	49	18
Montelukast Sodium	Montelukast Sodium	45	13
Metoprolol Tartrate	Metoprolol Tartrate	44	19
Pravastatin Sodium	Pravastatin Sodium	41	18
Quetiapine Fumarate	Quetiapine Fumarate	40	15
Clopidogrel	Clopidogrel Bisulfate	39	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	16
Trazodone Hcl	Trazodone Hcl	39	16
Zolpidem Tartrate	Zolpidem Tartrate	39	21
Olmesartan Medoxomil	Olmesartan Medoxomil	38	16
Duloxetine Hcl	Duloxetine Hcl	36	13
Eliquis	Apixaban	36	suppressed
Azelastine Hcl	Azelastine Hcl	35	16
Hydrochlorothiazide	Hydrochlorothiazide	34	15
Sertraline Hcl	Sertraline Hcl	33	14
Spironolactone	Spironolactone	31	11
Furosemide	Furosemide	30	16
Mounjaro	Tirzepatide	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Chlorthalidone	Chlorthalidone	29	14
Trulicity	Dulaglutide	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	15
Warfarin Sodium	Warfarin Sodium	26	suppressed
Breyna	Budesonide/Formoterol Fumarate	25	suppressed
Valsartan	Valsartan	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Prednisone	Prednisone	23	11
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Guanfacine Hcl	Guanfacine Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	12
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Glipizide	Glipizide	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Azithromycin	Azithromycin	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Temazepam	Temazepam	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Ozempic	Semaglutide	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Juluca	Dolutegravir/Rilpivirine	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error